Author: OurCrowd

[Clinch in PR Newswire] Clinch Doubles Headcount to Support Exponential Business Growth Across a Number of Verticals, Including Connected TV (CTV), Over-the-top (OTT), Digital Out-of-Home (DOOH), and Audio

Nov 30, 2021 |

NEW YORK, Nov. 30, 2021 /PRNewswire/ — Clinch, the company that leads the industry in AI-driven personalized advertising and dynamic ad-serving across CTV, OTT, programmatic, social, Native, audio, and DOOH, has announced they have more than doubled their headcount to support an over 250% increase in business growth with strategic new hires across its business development, sales, data science, ad ops, tech, and engineering teams. Clinch Co-Founder and CEO Oz Etzioni said, “Clinch is growing in all regions, globally, and our recent hires reflect not only that but our dedication to building out our product across a number of verticals. We have retained an impressive client roster that has grown over 250% year-over-year, and we intend to keep that momentum going.” Read more...

Read More

[SmartAsset in PR Newswire] Cetera extends investor acquisition program to all affiliated financial professionals based on organic growth results

Nov 30, 2021 |

Cetera Financial Group, one of America’s largest networks of financial professionals, today announced that its investor acquisition program is expanding to all Cetera-affiliated financial professionals and that participants are eligible for reimbursement of their investment into the program. LeadEngine, which is powered by SmartAsset – the largest lead generation platform for financial professionals – is Cetera’s exclusive investor acquisition program that connects financial professionals directly with highly qualified prospects who are actively seeking a financial professional. Read...

Read More

[SaNOtize in NoCamels] SaNOtize ramps up anti-Covid nasal spray production to keep up with demand

Nov 30, 2021 | ,

SaNOtize CEO Dr. Gilly Regev visited Israel earlier this month as she inspected the increase in manufacturing production of her company’s antiviral nasal spray, Enovid, which clinical tests have shown to be highly effective against many viruses, including the SARS-CoV-2, the virus that causes COVID-19, and all its variants – even Delta. Read more...

Read More